Skip to content
Biogena Nutrifem P-M-S Formula®
Menstrual cycle / PMS · capsules

Biogena Nutrifem P-M-S Formula®

60 capsules · 2 capsules per day

List price46.90 €60 capsules
Price/day1.56 €
Supply30 days
25 € discount
Code AD1131373
from 75 € order value
View product Advertising/Affiliate link
Current product/batch-specific notice: Not suitable for persons under 18 years. Because the daily dose provides 10 mg vitamin B6, additional B6-containing products should be considered when assessing total intake. (checked 16 Sep 2026)

Product description

Multi-ingredient formula with calcium, magnesium, iron, zinc, B vitamins and vitamin D3 plus chasteberry, ginkgo and maritime pine bark extract.

Checked: 16 Sep 2026• Ingredients list complete• Lab report available• without MCC• without silicon dioxide
Editorial assessment

Assessment by Oliver Fröhner

Micronutrient expert & Food Coach

Product character

The product combines several minerals, vitamins and botanical extracts rather than focusing on one nutrient. Magnesium, iron, zinc, vitamin D3 and the comparatively high vitamin B6 intake are particularly relevant from an orthomolecular perspective.

Formula & transparency

  • Ingredients list fully checked
  • Without microcrystalline cellulose according to the fully reviewed ingredient list
  • Without silicon dioxide according to the fully reviewed ingredient list
  • Product data reviewed within the freshness period

Points to consider

  • A current product- or batch-specific notice is available.

Data basis

  • Lab report available but not marked as reviewed
  • HPMC/hydroxypropyl methylcellulose is declared.

Summary by Oliver Fröhner

Multi-ingredient formula with calcium, magnesium, iron, zinc, B vitamins and vitamin D3 plus chasteberry, ginkgo and maritime pine bark extract.

Manufacturer information and Oliver Fröhner’s editorial assessment are presented separately. Data checked: 16 Sep 2026.

Active ingredients & NRV

Active ingredients

Iron Ferrous Bisglycinate 10 mg · per Daily dose71 % NRV
Ginkgo-biloba-Extrakt — 60 mg · per Daily dose
Vitamin B2 Sodium Riboflavin 5-Phosphate 4.2 mg · per Daily dose300 % NRV
Magnesium — 150 mg · per Daily dose40 % NRV
Proanthocyanidine — 21 mg · per Daily dose
Vitamin D3 Cholecalciferol (Vitamin D3) 15 µg · per Daily dose300 % NRV
Zinc Zinc Picolinate 10 mg · per Daily dose100 % NRV
Copper Kupfercitrat 1 mg · per Daily dose100 % NRV
Chasteberry Fruit Extract — 20 mg · per Daily dose
Calcium — 300 mg · per Daily dose38 % NRV
Vitamin B6 Pyridoxal 5-Phosphate 10 mg · per Daily dose714 % NRV
Maritime Pine Bark Extract — 30 mg · per Daily dose
Vitamin B1 Thiamine Mononitrate 1.1 mg · per Daily dose100 % NRV
Ingredients & additives

Calciumcarbonat, Biogena Viersalz®-Komplex (Magnesiumcitrat, Magnesiumoxid, Magnesiumgluconat, Magnesiumcarbonat), Hydroxypropylmethylcellulose (Kapselhülle), Füllstoff: Cellulosepulver; Ginkgo-biloba-Extrakt, Zinkpicolinat, Eisenbisglycinat, Seekiefer-Rindenextrakt (Pinus pinaster), Mönchspfeffer-Extrakt, Pyridoxal-5'-phosphat, Cholecalciferol, Natrium-Riboflavin-5'-phosphat, Kupfercitrat, Thiaminmononitrat.

without MCC without SiO₂
Directions & package

Take 2 capsules daily with plenty of liquid with a meal.

60 capsules · 30 days

Quality, lab & sources

Lab status: Lab report available

Product data checked on 16 Sep 2026.

Notes

Not suitable for persons under 18 years. Because the daily dose provides 10 mg vitamin B6, additional B6-containing products should be considered when assessing total intake.

Nutrient knowledge & reference values

Nutrient knowledge & reference values

General nutrient information for interpreting the product dosage. Signs of insufficient or excessive intake are non-specific and do not replace a diagnosis.

Magnesium

Magnesium is an essential mineral involved in numerous enzymatic reactions. For product assessment, the manufacturer’s dosage, active-ingredient forms and reference values are considered separately.

NRV 375 mg European Union · 2011 Product daily dose: 40 % of the reference value EU NRV for nutrition labelling; not a therapeutic target and not a safety limit. Source →
UL 250 mg EFSA / SCF · 2001 / EFSA Summary 2024 Product daily dose: 60 % of the UL; other intake sources are not included. UL for readily dissociable magnesium salts/magnesium oxide from food supplements or other added sources; naturally occurring magnesium from foods is not covered in the same way. Source →
UL 350 mg US FNB / NASEM (NIH ODS) · NIH ODS current Product daily dose: 43 % of the UL; other intake sources are not included. The US UL covers magnesium from dietary supplements and medicines, not magnesium naturally present in foods and beverages. Safety limit, not a target value. Source →

Functions

Magnesium contributes, among other things, to normal muscle and nerve function and to normal energy-yielding metabolic processes. It is also involved in processes related to protein, bone and DNA.

Possible signs of insufficient intake

Insufficient magnesium intake can present with nonspecific symptoms; possible indications may include neuromuscular complaints. Individual symptoms do not establish a diagnosis and should not be assessed in isolation.

Points to consider at high intake

High amounts from supplements can mainly cause gastrointestinal symptoms such as diarrhoea, nausea and abdominal cramps. With severely impaired kidney function, the risk of magnesium accumulation increases; high doses should then be medically assessed.

Special considerations

With impaired kidney function, magnesium excretion is reduced. Product dose, magnesium form, tolerance and total intake should therefore be considered separately.

Interactions / caution

Magnesium can affect the absorption of certain medicines, including some antibiotics and bisphosphonates. Timing intervals and individual medication should be reviewed with regular use.

Knowledge reviewed on 23 Sep 2026

Vitamin D3

Vitamin D is a fat-soluble vitamin and also a precursor of hormonally active metabolites. For the assessment of supplements, product dose, dosing interval, total intake, 25-OH-vitamin-D status and safety limits are considered separately.

NRV 200 IE European Union · 2011 EU NRV: 5 µg vitamin D, equivalent to 200 IU. Labelling reference value; not a therapeutic target and not a safety limit. Source →
UL 4,000 IE EFSA · EFSA current EFSA UL: 100 µg vitamin D per day, equivalent to 4,000 IU. Safety limit for long-term intake, not an optimal target value. Source →
UL 4,000 IE US FNB / NASEM (NIH ODS) · NIH ODS current US UL: 100 µg or 4,000 IU of vitamin D per day for adults. Safety limit, not a target value. Source →

Functions

EU-authorised functions include, among other things: vitamin D contributes to normal absorption and utilisation of calcium and phosphorus, normal blood calcium levels, the maintenance of normal bones and teeth, normal muscle function and normal functioning of the immune system. Vitamin D also has a role in the process of cell division.

Possible signs of insufficient intake

Inadequate vitamin D status cannot be reliably identified from individual nonspecific symptoms. For individual assessment, 25-OH-vitamin-D status together with exposure, diet and supplemental intake is more informative than symptoms alone.

Points to consider at high intake

A markedly excessive vitamin D intake over a prolonged period can lead to hypercalcaemia and hypercalciuria and thereby place a burden on the kidneys and other organ systems. Upper Intake Levels are safety limits for long-term intake and are not optimal target values.

Special considerations

Particular caution is required, among other situations, with diseases or therapies that affect calcium metabolism or kidney function. High doses should not be derived solely from general target values.

Interactions / caution

Vitamin D can interact with certain medicines; relevant examples include drugs that affect calcium or vitamin D metabolism. With prolonged higher-dose use, individual medication should be taken into account.

Knowledge reviewed on 23 Sep 2026

Zinc

Zinc is an essential trace element. The assessment considers the EU NRV, total intake, product dose and interactions—particularly with copper and medicines—separately.

NRV 10 mg European Union · 2011 Product daily dose: 100 % of the reference value EU NRV for nutrition labelling; not a therapeutic target and not a safety limit. Source →
UL 25 mg EFSA / SCF · 2002 / EFSA Summary 2024 Safety limit for long-term intake; not a target value. Source →
UL 40 mg US FNB / NASEM (NIH ODS) · NIH ODS current Product daily dose: 25 % of the UL; other intake sources are not included. US UL for zinc from all sources. Safety limit, not a target value. Source →

Functions

EU-authorised health-claim functions include, among other things: zinc contributes to the normal function of the immune system, normal cognitive function, normal DNA synthesis, normal fertility and reproduction, and normal acid-base and carbohydrate metabolism. Zinc contributes to the maintenance of normal bones, hair, nails, skin and vision, protects cells from oxidative stress and has a role in the process of cell division.

Possible signs of insufficient intake

Zinc deficiency can be associated, among other things, with loss of appetite, impaired taste and smell, delayed wound healing, hair loss, growth impairment and increased susceptibility to infections. These symptoms are nonspecific and do not allow self-diagnosis.

Points to consider at high intake

Excessive zinc intake can cause nausea, vomiting, headaches and gastrointestinal symptoms. Chronically high amounts can inhibit copper absorption and thereby promote copper deficiency. The European EFSA/SCF UL for adults is 25 mg of zinc per day from total intake.

Special considerations

An increased risk of inadequate zinc intake exists, among other situations, with certain gastrointestinal diseases or after bariatric surgery, with strongly plant-based diets with low zinc bioavailability, during pregnancy and breastfeeding, and with chronically high alcohol consumption.

Interactions / caution

Zinc can reduce the absorption of quinolone and tetracycline antibiotics as well as penicillamine; dosing intervals should be observed. Thiazide diuretics can increase zinc excretion. Long-term high zinc intake can reduce copper absorption.

Knowledge reviewed on 23 Sep 2026

Copper

Copper is an essential trace element and a component of numerous enzyme systems. Product dose, total intake and the relationship with other trace elements—especially zinc—should be assessed separately.

NRV 1 mg European Union · 2011 Product daily dose: 100 % of the reference value EU NRV for nutrition labelling; not a therapeutic target and not a safety limit. Source →
UL 5 mg EFSA / SCF · 2003 / EFSA Summary 2024 Safety limit for long-term total intake; not a target value. Source →
UL 10 mg US FNB / NASEM (NIH ODS) · NIH ODS current Product daily dose: 10 % of the UL; other intake sources are not included. US UL: 10 mg or 10,000 µg of copper per day from all sources. Safety limit, not a target value. Source →

Functions

EU-authorised health-claim functions include: copper contributes to the maintenance of normal connective tissues, normal energy-yielding metabolism, normal functioning of the nervous system and immune system, and the protection of cells from oxidative stress. It also contributes to normal iron transport in the body and to normal hair and skin pigmentation.

Possible signs of insufficient intake

Copper deficiency is rare. Reported signs include pronounced fatigue, abnormalities of connective tissue and bone, neurological symptoms, impaired coordination and increased susceptibility to infections. Diagnosis of deficiency requires professional assessment.

Points to consider at high intake

Chronically excessive copper intake can cause nausea, abdominal pain, vomiting, diarrhoea and liver damage, among other effects. The European EFSA/SCF UL for adults is 5 mg of copper per day from total intake. Special medical requirements apply in Wilson disease.

Special considerations

An increased risk of inadequate copper status may occur, among other situations, in coeliac disease, rare disorders of copper metabolism such as Menkes disease, and with long-term very high zinc intake. For people with Wilson disease, additional copper intake without medical supervision is not appropriate.

Interactions / caution

High zinc intake can reduce intestinal copper absorption and, with prolonged use, promote copper deficiency. No widespread clinically relevant drug interactions are established for copper; disease-specific situations such as Wilson disease require medical management.

Knowledge reviewed on 23 Sep 2026

Vitamin B6

UL 12 mg EFSA · 2023 Product daily dose: 83 % of the UL; other intake sources are not included. EFSA UL 12 mg/day for adults; includes total intake from foods and supplements and all vitamin B6 vitamers. Safety limit, not a target value. Source →
UL 100 mg US FNB / NASEM (NIH ODS) · NIH ODS current Product daily dose: 10 % of the UL; other intake sources are not included. US UL 100 mg/day for adults from food and supplement sources. Considerably higher than the EFSA UL newly derived in 2023; note the different derivation methods. Source →
Science & studies

Scientific assessment

Studies, meta-analyses and randomized controlled trials on the active ingredient – explained clearly and linked to sources.

Discount code AD1131373
View product Advertising/Affiliate link

The information is provided for factual classification of product and nutrient data. It does not replace medical diagnosis or individual treatment advice.

Click to access the login or register cheese
Moleqlar experiences

As a scientific co-operation partner of Moleqlar, we have the opportunity to provide you with a discount code for your purchase at Moleqlar. As a micronutrient expert, I am happy to assist you with any questions you may have about Moleqlar products.

10% discount code for moleqlar